Related Experiment Video
Updated: Jun 1, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary hypertension for primary care providers
Mark A Thompson1, Avery P McKee, Hamang Patel
1Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA.
Pulmonary hypertension (PH) presents with symptoms like shortness of breath and fatigue. Recent research has advanced PH therapies, making them applicable to all patients and aiding primary care physicians in diagnosis and management.
Area of Science:
- Cardiovascular Medicine
- Pulmonology
- Medical Research
Background:
- Pulmonary hypertension (PH) is a complex condition characterized by symptoms such as dyspnea, fatigue, chest pain, palpitations, and syncope.
- Significant research advancements in the last decade have altered the disease's natural progression.
- Therapies targeting molecular causes of increased pulmonary vascular resistance are now broadly applied.
Purpose of the Study:
- To highlight recent therapeutic advances in pulmonary hypertension.
- To emphasize the evolving role of primary care physicians in diagnosing and managing PH.
- To identify key challenges in PH identification and treatment.
Main Methods:
- Review of recent research and therapeutic strategies for pulmonary hypertension.
- Analysis of the application of targeted therapies across different PH types.
- Discussion of diagnostic and management challenges in primary care settings.
Main Results:
- Therapies initially for specific molecular targets are now used across all pulmonary hypertension patient groups.
- The natural history of pulmonary hypertension has been significantly modified by recent research.
- Identifying PH and its modifiable factors remains a critical task for primary care.
Conclusions:
- Pulmonary hypertension management has benefited from broad application of advanced therapies.
- Primary care physicians face challenges in early identification and determining modifiable substrates for PH.
- Continued research is crucial for improving outcomes in pulmonary hypertension.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
